Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus

Background. Hepatitis B virus (HBV) infections are perinatally transmitted from chronically infected mothers. Supplemental antiviral therapy during late pregnancy with lamivudine (LAM), telbivudine (LdT), or tenofovir (TDF) can substantially reduce perinatal HBV transmission compared to postnatal im...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PeerJ
Päätekijät: Wang, Wenjun, Wang, Jingjing, Dang, Shuangsuo, Zhuang, Guihua
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: PeerJ Inc. 2016
Aiheet:
Health Policy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4811175/
https://ncbi.nlm.nih.gov/pubmed/27042389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.1709
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia